Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Baxter
AstraZeneca
Colorcon
Moodys
Express Scripts

Last Updated: October 24, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022404

See Plans and Pricing

« Back to Dashboard

NDA 022404 describes ORAVIG, which is a drug marketed by Midatech Pharma Us and is included in one NDA. It is available from one supplier. There are three patents protecting this drug. Additional details are available on the ORAVIG profile page.

The generic ingredient in ORAVIG is miconazole. There are twenty-eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the miconazole profile page.
Summary for 022404
Tradename:ORAVIG
Applicant:Midatech Pharma Us
Ingredient:miconazole
Patents:3
Formulation / Manufacturing:see details
Pharmacology for NDA: 022404
Suppliers and Packaging for NDA: 022404
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ORAVIG miconazole TABLET;BUCCAL 022404 NDA Midatech Pharma US, Inc. 89141-250 89141-250-02 1 BOTTLE in 1 CARTON (89141-250-02) > 2 TABLET in 1 BOTTLE
ORAVIG miconazole TABLET;BUCCAL 022404 NDA Midatech Pharma US, Inc. 89141-250 89141-250-14 1 BOTTLE in 1 CARTON (89141-250-14) > 14 TABLET in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;BUCCALStrength50MG
Approval Date:Apr 16, 2010TE:RLD:Yes
Patent:  Start TrialPatent Expiration:Sep 11, 2022Product Flag?YSubstance Flag?Delist Request?
Patented Use:TREATMENT OF OROPHARYNGEAL CANDIDIASIS
Patent:  Start TrialPatent Expiration:Sep 11, 2022Product Flag?Substance Flag?Delist Request?
Patented Use:TREATMENT OF OROPHARYNGEAL CANDIDIASIS
Patent:  Start TrialPatent Expiration:Sep 11, 2022Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
AstraZeneca
Merck
Mallinckrodt
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.